1. Makarov VA, Spasov AA, Plotnikov MB, Belozerskaya GG, Vasil’eva TM, Drozd NN, Svistunov AA, Kucheryavenko AF, Malykhina LS, Naumenko LV, Neverdora OE, Petrukhina GN, Aliev OI, Plotnikova TM. Methodical recommendations for study of drugs that affect hemostasis. Methodical recommendations for the study of drugs affecting hemostasis. Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. P. 453-479. Russian.
2. Bush JR, Liang H, Dickinson M, Botchwey EA. Xylan hemicellulose improves chitosan hydrogel for bone tissue regeneration. Polym. Adv. Technol. 2016;27(8):1050-1055.
3. Campbell A, Nesheim ME, Doctor VM. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans. Thromb. Res. 1987;47(3):341-352.
4. Carson L, Doctor V. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans. Thromb. Res. 1990;58(4):367-381.
5. Ebringerová A, Heinze T. Xylan and xylan derivatives — biopolymers with valuable properties, 1. Naturally occurring xylans structures, isolation procedures and properties. Macromol. Rapid. Commun. 2000;21(9):542-556.